Flexible Funds (2009-2017)

A quantitative analysis of nigral stimulation for gait disturbances in patients with Parkinson's disease

The randomized double-blind controlled Phase II study investigates the influence of combined stimulation of the subthalamic nucleus (STN) and substantia nigra pars reticulata (SNr) on gait using the gait assessment system “Mobility Lab”.

Project Director: Prof. Dr. Andrea Kühn (Neurology CVK)

Identification of novel antigenic targets and disease mechanisms in patients with autoantibody-mediated brain disorders (NOVAB-IND: NOVel AntiBodies In Neurological Disorders)

The observational study aims for the identification of patients with autoantibodies targeting novel proteins.

Project Director: Prof. Dr. Andreas Meisel (NCRC, CSB, Neurology CCM)

Partner: PD Dr. Harald Prüss (Neurology CCM)

Status Epilepticus in SubArachnoid Hemorrhage

The SESAH study has been nested as an independent study in the clinical trial “Depolarizations in ISChemia after subarachnoid hemorrhaGE-1 (DISCHARGE-1)”. The study is a bicenter diagnostic phase I study investigating status epilepticus after subarachnoid hemorrhage (aSAH).

Project Director: Prof. Dr. Uwe Heinemann (Institute of Neurophysiology CVK)

Partners: Prof. Dr. Jens Dreier, Karl Schoknecht (CSB)

Chemotherapy-induced cognitive alterations in recruits with ovarian cancer

The longitudinal observational study examines neurotoxic side effects in ovarian cancer patients treated with paclitaxel combination chemotherapy.

Project director: Prof. Dr. Matthias Endres (CSB, Neurology)

Oscillatory brain stimulation during sleep to improve memory consolidation in patients with mild cognitive impairment

In this mono-center, randomized, rater-blinded, placebo-controlled proof-of-concept study, patients with mild cognitive impairment will receive either an oscillatory brain or sham stimulation to investigate whether oscillatory brain stimulation can improve memory consolidation.

Project Director: Prof. Dr. Agnes Flöel (NCRC, CSB, Neurology CCM) 

Evaluation of instrumented testing of upper body function in patients with dystonia

The aim of this mono-center diagnostic pilot trial is to develop a camera-based assessment of upper body function in dystonia that is able to predict therapeutic response at an earlier time point than with clinical judgment alone.

Project Director: Prof. Dr. Andrea Kühn (Neurology CVK) 

Endothelial activation, cerebral small vessel disease and cognition in the Berlin Aging Study II (BASE)

In this cross-sectional study, data from the longitudinal study BASE II will be analyzed to investigate the hypothesis that low levels of stromal-derived factor-1 in elderly subjects are associated with the severity of cerebral small vessel disease.

Project Director: Prof. Dr. Matthias Endres (CSB, Neurology)

Impact of cerebral ischemia on the composition of the gut microbiota

In this prospective observational proof-of-concept study, stool as well as a blood samples will be collected from stroke patients and a control group to investigate the hypothesis that cerebral ischemia induces changes in the human gut microbiome and that the gut microbiome of stroke patients differs from that of the non-stroke population.

Project Director: Prof. Dr. Ulrich Dirnagl (CSB, Neurology CCM)

A pilot study on the B cell repertoire in Neuromyelitis optica

In this mono-center explorative diagnostic pilot study the B cell repertoire in patients with Neuromyelitis optica and Neuromyelitis optica spectrum disorders will be compared to patients with multiple sclerosis as well as longitudinally under immune therapy to investigate the role of B cells in these patients.

Project Director: Prof. Dr. Anja Hauser (DRFZ) 

Effects of over-nutrition on functions of the Central Nervous System

This mono-center study will investigate the effect of over-nutrition on different central nervous system functions. Samples of obese patients will be compared to those of normal‐weight, age- and sex‐matched controls.

Project Director: Prof. Dr. Frank Heppner (Neuropathology CCM) 

Preventive antiinfective therapy in acute ischemic stroke using inhaled IFN-y

This mono-center, randomized, placebo-controlled, double-blind study will investigate the safety of inhaled interferon-y and its efficacy in the prevention of stroke-associated pneumonia in patients with acute severe ischemic stroke.

Project Director: Prof. Dr. Andreas Meisel (NCRC, CSB, Neurology CCM)

Baclofen for the treatment of alcohol dependency 

A monocentric, randomized, placebo-controlled, double-blind pilot study for the investigation of the efficacy of Baclofen in the prevention of relapses in alcohol-dependent patients.

Project Director: Prof. Dr. Andreas Heinz (Psychiatry CCM)

Clinical establishment of a new kind of classification system for adult Moyamoya Disease.

Project Director: Prof. Dr. Frank Heppner (Neuropathology) in cooperation with Dr. Marcus Czabanka (Neurosurgery CBF)

An exploratory diagnostic study on mutations in PSD associated protein MAGI2 as cause of severe childhood epilepsies.

Project Director: Prof. Dr. Markus Schülke-Gerstenfeld (NCRC, Pediatrics CVK)

Training in older people with disturbed glucose tolerance: advantageous for blood vessels and nerve cells?

A monocentric, prospective, single-blind, randomized, placebo-controlled study for the examination of the effect of "Nordic Walking“ on memory performance and on vascular functions in older people.

Project Director: Prof. Dr. Agnes Flöel (CSB, Neurology CCM)

A proof-of-principle study for the modulation of the congenital immune system using Interferon-beta in patients with clinically isolated syndrome and multiple sclerosis.

Project Director: Prof. Dr. Seija Lehnardt (Neurology CCM) in cooperation with Dr. Klemens Ruprecht (Neurology CCM)

Beta-blockers in the treatment of acute ischemic stroke 

A randomized, double-blind, placebo-controlled study on the toleration and efficacy of early treatment of stroke patients with beta-blockers. It is intended to prevent both cardiac and infectious complications.

Project Director: Prof. Dr. Wilhelm Haverkamp (Cardiology CVK) in cooperation with Prof. Dr. Andreas Meisel (NCRC, CSB, Neurology CCM)

Carbon dioxide in the treatment of febrile convulsions 

A monocentric, randomized, placebo-controlled, double-blind pilot study for the evaluation of the therapeutic administering of Carbogen for stopping seizures.

Project Director: Prof. Dr. Dietmar Schmitz (NeuroCure, NWFZ) in cooperation with Prof. Dr. Markus Schülke-Gerstenfeld (NCRC, Pediatrics CVK)

Endothelial function and precursor cells in acute ischemic stroke in the framework of the Cream&Sugar study. You can receive more detailed information here.

Project Director: Prof. Dr. Matthias Endres (CSB, Neurology)

Effects of EGCG (epigallocatechin gallate) in Huntington's disease 

A multi-center, randomized, placebo-controlled, double-blind study for investigation of the hypothesis that Sunphenon EGCG can improve cognitive performance in patients with Huntington's chorea.

Project Director: Prof. Dr. Josef Priller (Laboratory of Molecularly Psychiatry, Psychiatry CCM) in cooperation with Prof. Dr. Friedemann Paul (NCRC)